{
    "nct_id": "NCT03893422",
    "official_title": "An Placebo-Controlled Clinical Nutrition Study to Evaluate the Metabolic Effects of Two Medical Food Products in Subjects With Type 2 Diabetes Treated With Diet and Exercise Alone or in Combination With Metformin ± Sulfonylurea",
    "inclusion_criteria": "* Type 2 diabetes treated with diet and exercise alone or in combination with metformin and/or sulfonylurea\n* If treated with metformin and/or sulfonylurea, must have been on a stable dose of the drug(s) for a minimum of 3 months with a stable A1c value\n* If treated with diet and exercise alone, must have one of the following:\n\n  * Documented fasting plasma glucose >126 mg/dL\n  * A1c value ≥6.8%\n* If treated with diet and exercise + metformin and/or sulfonylurea, must have a stable A1c between 6.8% and 11.0% for 3 months prior study entry\n* BMI >25 but <45 and weight stable within +/- 5% over past 3 months\n* If female, must meet all the following criteria:\n\n  * Not pregnant or breastfeeding\n  * If of childbearing potential (including peri-menopausal women with menstruation during past year) must practice and be willing to continue appropriate birth control during the entire duration of the study\n* Have a home freezer available for immediate freezing of stool samples\n* Able to read, understand, and sign the informed consent form (ICF) and HIPAA authorization when applicable,\n* Able to communicate with the investigator, and understand and comply with protocol requirements\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
    "exclusion_criteria": "* Use of antibiotic, antifungal, antiparasitic, or antiviral therapy within 30 days prior to study entry\n* Planned use or antibiotic, antifungal, antiparasitic, or antiviral treatment during the study period\n* Subjects using a proton pump inhibitor must be on a stable dose that will be maintained throughout the study period\n* Present use of probiotics/nutritional supplements. (Note: Use of replacement doses of Vitamin D, calcium supplements, and a single daily multi-vitamin tablet allowed)\n* Participation in a structured weight-loss program within the past 2 months\n* Change in body weight ≥5% within the past month\n* Excess alcohol consumption; with an alcoholic drink defined as 12 fluid ounces of beer (5% alcohol), 5 fluid ounces of wine (12% alcohol) or 1.5 fluid ounces of 80 proof distilled spirits\n\n  * Women: More than 2 alcoholic drinks/day or more than 7 drinks/week\n  * Men: More than 3 alcoholic drinks/day or more than 10 drinks/week\n* Travel outside United States within 30 days of study entry\n* Planned travel outside United States during study period\n* Use of an experimental drug within 30 days prior to study entry\n* Known milk, peanut, tree nut, wheat, soy or shellfish allergy\n* Diagnosis of a sexually transmitted disease including, but not limited to, HIV, syphilis, herpes, gonorrhea, hepatitis A, hepatitis B, and hepatitis C\n* Hospitalization during last 3 months (Same day surgery center procedures allowed)\n* Active GI disease\n* Gastrointestinal tract surgery (appendectomy and cholecystectomy allowed)\n* Cystic fibrosis\n* Any condition deemed by the investigator to disqualify subject",
    "miscellaneous_criteria": ""
}